What is coronary ectasia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Definition of Coronary Ectasia

  • Coronary artery ectasia (CAE) is defined as a diffuse or focal dilation of an epicardial coronary artery, which diameter exceeds by at least 1.5 times the normal adjacent segment 1, 2, 3
  • CAE can be further subdivided into diffuse and focal dilations by the number and the length of the dilated vessels 1
  • It is characterized by abnormal dilatation of the coronary arteries, often associated with atherosclerosis, inflammation, and other diseases 1, 2, 4, 3, 5

Prevalence and Etiology

  • The prevalence of CAE ranges between 0.3 and 5% of patients undergoing coronary angiography 1, 3
  • Atherosclerosis is the most common etiology of CAE in adults, while Kawasaki disease is the most common in children 1
  • Other etiological factors include systemic connective tissue diseases, infectious diseases, vasculitis, congenital anomalies, genetic factors, and idiopathic CAE 1
  • CAE is also associated with sickle cell disease, with an incidence of 17.7% 2

Clinical Implications and Prognosis

  • Patients with CAE typically present with angina, and are at risk for myocardial infarctions and sudden cardiac death due to slow flow, coronary vasospasm, dissection, and/or intracoronary thrombosis 2, 3, 5
  • The prognostic role of CAE is controversial, but previous studies reported a high risk of cardiovascular events and mortality in these patients after percutaneous coronary intervention 3
  • Treatment of underlying condition and avoidance of exacerbating factors are essential, and therapy should be tailored to each individual case after assessment of severity, history of complications, underlying etiology, and comorbidities 1, 2, 3

Treatment and Management

  • Medical therapy with anticoagulants, nitrates, and calcium channel blockers has been proposed and seems rational, however prospective studies with proof of efficacy are needed 2, 4, 5
  • Interventional management of patients with CAE, including covered stent implantation and stent-assisted coil embolization, is challenging and often complicated by distal thrombus embolization and stent malapposition 3
  • The optimal antithrombotic therapy is debated and includes dual antiplatelet therapy, anticoagulation, or a combination of them 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.